Marco Tori

Michigan State University

Papers

1

Total Citations

22

H-Index

1

About

Marco Tori is a leading figure in urologic oncology, with a focused expertise in nephrometry scoring systems and their application to renal cancer surgery. His work centers on refining preoperative imaging assessments to improve surgical planning and predict patient outcomes after partial nephrectomy. Tori’s most influential contribution is his comparative analysis of four major nephrometry scores—RENAL, PADUA, CSA, and PAVP—in a landmark 2018 study. This work systematically evaluated how each score correlates with postoperative functional kidney outcomes, providing clinicians with critical evidence to choose the most predictive tool for preserving renal function. The study, which has garnered 22 citations, remains a key reference for surgeons seeking to balance oncologic control with nephron-sparing goals. Beyond this core contribution, Tori’s research portfolio demonstrates a commitment to translating anatomical complexity into actionable clinical insights, helping to standardize risk assessment in nephron-sparing surgery. His work is particularly valued by urologists and radiologists who rely on reproducible metrics to guide patient counseling and operative strategy.

Research Focus

Key Achievements

1
H-Index
1
Papers
22
Total Citations
22
Avg Citations/Paper
🏆 Most Cited Paper
Comparison of RENAL, PADUA, CSA, and PAVP Nephrometry Scores in Predicting Functional Outcomes After Partial Nephrectomy
22 citations · 2018
📈 Most Prolific Year: 2018 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: Michigan State University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago